NorthRock Partners’s Vericel Corp VCEL Stock Holding History
Bought
Maintained
Sold
Other funds holding VCEL
CAM
CCA
GKIM
SCM
NorthRock Partners's VCEL Position: Q2 2026 in Review
NorthRock Partners opened a new position in Vericel Corp (VCEL) in Q2 2026: 4,744 shares worth $211K. The stake represents ﹤0.01% of the portfolio and ranks #635 among its holdings. This is a return to the name: NorthRock Partners previously reported a position in VCEL as recently as Q2 2025.
NorthRock Partners first reported a position in VCEL in Q4 2018 and has held it in 13 quarters since. The position peaked at $485K in Q4 2018. 319 funds tracked by Wall St. Rank hold VCEL as of Q2 2026.
- NorthRock Partners held 4,744 shares of Vericel Corp worth $211K as of Q2 2026.
- Vericel Corp was a new NorthRock Partners position in Q2 2026.
- Vericel Corp made up ﹤0.01% of NorthRock Partners's portfolio in Q2 2026, its #635 holding.
- NorthRock Partners first reported a position in Vericel Corp in Q4 2018 and has held it in 13 quarters since.
- NorthRock Partners's Vericel Corp position peaked at $485K in Q4 2018.
- 319 funds tracked by Wall St. Rank held Vericel Corp as of Q2 2026.
Based on NorthRock Partners's 13F filing for Q2 2026, filed 11 Aug 2026.